Home/Filings/4/0001209191-22-021524
4//SEC Filing

Kim Dong 4

Accession 0001209191-22-021524

CIK 0001668243other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 7:14 PM ET

Size

5.3 KB

Accession

0001209191-22-021524

Insider Transaction Report

Form 4
Period: 2022-03-25
Kim Dong
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-25+30,00030,000 total
    Exercise: $8.61Exp: 2032-03-24Ordinary Shares (30,000 underlying)
Footnotes (1)
  • [F1]One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025.

Issuer

UroGen Pharma Ltd.

CIK 0001668243

Entity typeother

Related Parties

1
  • filerCIK 0001920163

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 7:14 PM ET
Size
5.3 KB